超1000亿元！成都未来产业基金重磅发布

Core Viewpoint - The Chengdu Future Industry Fund, with a total scale exceeding 100 billion yuan, was launched to support the development of future industries in Chengdu [1][2]. Group 1: Fund Structure and Management - The fund is managed by Chengdu Sci-Tech Investment Group and is based on the "industrial fund" of Chengdu Industrial Investment Group and the "functional fund" of Jiaozi Financial Holdings Group [2]. - Chengdu Sci-Tech Investment Group has invested in 600 technology innovation enterprises and future projects, demonstrating its capability to manage long-term, high-risk future industry funds [2][5]. Group 2: Investment Focus and Strategy - The fund will focus on a modern industrial system categorized as "9+9+10," emphasizing areas such as humanoid robots, flying cars, intelligent perception, and next-generation mobile communications [5]. - The Future Industry Angel Fund aims to address the "market failure" faced by seed and early-stage technology companies, filling the gap left by traditional financial systems in early-stage investments [5]. - The Future Industry Venture Capital Fund will support innovative enterprises in their growth and scaling processes, facilitating their transformation from "1 to 100" [5]. Group 3: Fund Ecosystem and Growth - Chengdu Sci-Tech Investment Group has established a comprehensive fund matrix covering the entire lifecycle of enterprises, including angel, VC, PE, and acquisition funds [6][7]. - A 2 billion yuan Chengdu Angel Mother Fund was set up for early-stage investments, achieving a capital multiplication of 7.46 times within a year [7]. - The group has also formed partnerships for satellite internet industry chain funds and established the first S fund in Sichuan, with a total scale of 9.9 billion yuan, leveraging funds to support over 300 small and medium-sized technology enterprises [7]. Group 4: Future Plans - Chengdu Sci-Tech Investment Group plans to continue nurturing the technology innovation ecosystem and stimulate industrial vitality through a "patient capital" approach [8].